Skip to Main Content

Author Details

Mary K McCarthy
University of Colorado School of Medicine
2012
33
16
PMIDPaper TitleJournal TitlePublished Year
37071849Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection.Am J Respir Cell Mol Biol2023
37873393Chikungunya virus infection disrupts lymph node lymphatic endothelial cell composition and function via MARCO.bioRxiv2023
30656438Chronic Chikungunya Virus Disease.Curr Top Microbiol Immunol2022
33452828Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.Transfusion2021
33795412Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA.J Clin Microbiol2021
33500361A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection.J Clin Microbiol2021
34676370Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication <i>in vitro</i>.Precis Nanomed2021
34618370MARCO<sup>+</sup> lymphatic endothelial cells sequester arthritogenic alphaviruses to limit viremia and viral dissemination.EMBO J2021
34046161Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement.Pulm Circ2021
34303688Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.J Immunol Methods2021
32348764Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross.Cell Rep2020
31999809MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2.PLoS Pathog2020
31862709Correction: Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response.J Immunol2020
31794434Chikungunya virus replication in skeletal muscle cells is required for disease development.J Clin Invest2020
32102875Chikungunya Virus Evades Antiviral CD8<sup>+</sup> T Cell Responses To Establish Persistent Infection in Joint-Associated Tissues.J Virol2020
32550013The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates.NPJ Vaccines2020
31596239Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses.Elife2019
31578287Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.J Virol2019
30045970Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response.J Immunol2018
29997290Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment.JCI Insight2018
30212644Blocking the Exit: CHIKV Neutralizing Antibodies Nip Viral Egress in the Bud.Cell Host Microbe2018
28214732Persistent RNA virus infections: do PAMPS drive chronic disease?Curr Opin Virol2017
26795547Prostaglandin E2 production during neonatal respiratory infection with mouse adenovirus type 1.Virus Res2016
27560373Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection.Virology2016
26939523Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms?Future Microbiol2016
25320326Proinflammatory effects of interferon gamma in mouse adenovirus 1 myocarditis.J Virol2015
26436766Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells.PLoS Pathog2015
26407316Prostaglandin E2 Production and T Cell Function in Mouse Adenovirus Type 1 Infection following Allogeneic Bone Marrow Transplantation.PLoS One2015
25688236The immunoproteasome and viral infection: a complex regulator of inflammation.Front Microbiol2015
24889245IL-17 contributes to neutrophil recruitment but not to control of viral replication during acute mouse adenovirus type 1 respiratory infection.Virology2014
24147040Prostaglandin E2 induction during mouse adenovirus type 1 respiratory infection regulates inflammatory mediator generation but does not affect viral pathogenesis.PLoS One2013
22345470Susceptibility to acute mouse adenovirus type 1 respiratory infection and establishment of protective immunity in neonatal mice.J Virol2012
22665949Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets.Mediators Inflamm2012
  • 1 - 33 of 33

Recommended Authors

Yale School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2016
Number of shared co-authors 13
University of California berkeley
Career Start Year 2014
Number of shared co-authors 3
Yale University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 2
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 10
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
Institute of Veterinary Disease Control
Career Start Year 2006
Number of shared co-authors 0
University of California san francisco
Career Start Year 2006
Number of shared co-authors 1
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2005
Number of shared co-authors 15
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 0
Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 15
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 5
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 6
Icahn School of Medicine at Mount Sinai
Career Start Year 1998
Number of shared co-authors 5
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 1
Institute of Immunity, Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 4
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 14
National Institute of Allergy and Infectious Diseases
Career Start Year 1995
Number of shared co-authors 2
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 5
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 11
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 1
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 8
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 5
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 2
Yale University
Career Start Year 1990
Number of shared co-authors 4
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 14

Collaborators

University of Colorado Anschutz Medical Campus
Co-authored papers 24
Co-authored papers 7
Washington University School of Medicine
Co-authored papers 2
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 1
University of North Carolina at Chapel Hill
Co-authored papers 1
University of North Carolina at Chapel Hill.
Co-authored papers 1
Knight Cancer Institute Oregon Health & Science University Portland Oregon USA.
Co-authored papers 1
Helmholtz Centre for Infection Research
Co-authored papers 1
Helmholtz Centre for Infection Research
Co-authored papers 1
University of North Carolina
Co-authored papers 1
University of North Carolina School of Medicine
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
Vanderbilt University School of Medicine
Co-authored papers 1
University of North Carolina at Chapel Hill
Co-authored papers 1
The University of North Carolina at Chapel Hill
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
University of North Carolina at Chapel Hill
Co-authored papers 1
University of Tennessee Health Science Center
Co-authored papers 1
University of North Carolina.
Co-authored papers 1
University of North Carolina at Chapel Hill
Co-authored papers 1
University of North Carolina
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
University of North Carolina at Chapel Hill
Co-authored papers 1
Indiana University School of Medicine
Co-authored papers 1
University of North Carolina at Chapel Hill
Co-authored papers 1
University of North Carolina
Co-authored papers 1
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Co-authored papers 1